You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 13, April 2, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Neurology
 •Cognitive Disorders
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Psychiatry
 •Delirium
 •Alert me on articles by topic

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their randomized trial, Dr Pandharipande and colleagues1 concluded that sedation with an infusion of dexmedetomidine resulted in more days alive without delirium or coma and more time at the targeted level of sedation compared with an infusion of lorazepam. However, clinicians should not conclude that use of dexmedetomidine was associated with a decrease in the incidence of ICU delirium given that a combined delirium and coma end point was used to define acute brain dysfunction, and delirium-free days rather than the incidence of delirium at any time during ICU stay was reported. The incidence of delirium at any time in the ICU may be a better predictor of patient outcome than the number of hours that a patient spends in delirium.2

In addition, the article did not present the breakdown of patients who were deemed to have delirium using the disorganized thinking feature of the Confusion . . . [Full Text of this Article]

Jeffrey F. Barletta, PharmD
jeffrey.barletta@spectrum-health.org
Spectrum Health
Grand Rapids, Michigan

John W. Devlin, PharmD
Northeastern University School of Pharmacy
Boston, Massachusetts


RELATED ARTICLE

Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated Patients: The MENDS Randomized Controlled Trial
Pratik P. Pandharipande, Brenda T. Pun, Daniel L. Herr, Mervyn Maze, Timothy D. Girard, Russell R. Miller, Ayumi K. Shintani, Jennifer L. Thompson, James C. Jackson, Stephen A. Deppen, Renee A. Stiles, Robert S. Dittus, Gordon R. Bernard, and E. Wesley Ely
JAMA. 2007;298(22):2644-2653.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients
Bryan Dotson and Michael J. Peeters
JAMA. 2008;299(13):1540.
EXTRACT | FULL TEXT  

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients
Hannah Wunsch and Joseph S. Meltzer
JAMA. 2008;299(13):1540-1541.
EXTRACT | FULL TEXT  

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients—Reply
Pratik P. Pandharipande, Timothy D. Girard, and E. Wesley Ely
JAMA. 2008;299(13):1542.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.